08:00–08:45
|
|
Meet the Expert Sessions 6–10
|
08:00 |
M06 |
Hematology—hematopoietic stem cell transplantation |
|
|
Nikolai Klimko, FECMM, Russia & Tony Pagliuca, UK
|
08:00 |
M07 |
Molecular Diagnostics |
|
|
Maurizio Sanguinetti, Italy & Dieter Buchheidt, FECMM, Germany
|
08:00 |
M08 |
Surgery/Transplantation |
|
|
Patricia Munoz, Spain & Paolo Grossi, Italy
|
08:00 |
M09 |
Neonates |
|
|
Thomas Walsh, FECMM, USA & Emmanuel Roilides, FECMM, Greece
|
08:00 |
M10 |
Meet Mr. and Mrs. Fungus |
|
|
Cornelia Lass-Flörl, FECMM, Austria & Neil Gow, FECMM, UK
|
08:50–09:50
|
|
Plenary Session 4—Top 10 papers in Mycology
|
|
|
Chairs: Maiken Arendrup, Denmark & Malcolm Richardson, FECMM, UK
|
08:50 |
PS4.1 |
The Clinical and Translational Perspective |
|
|
Don Sheppard, FECMM, Canada
|
09:20 |
PS4.2 |
The Microbiology Perspective |
|
|
Katrien Lagrou, FECMM, Belgium
|
|
|
ECMM Academy and Excellence Centers: A Story of Success
|
|
|
Chair: Martin Hoenigl, FECMM, Austria
|
09:50 |
|
ECMM Academy |
|
|
Katrien Lagrou, FECMM, Belgium
|
09:55 |
|
ECMM Excellence Centers |
|
|
Cornelia Lass-Flörl, FECMM, Austria
|
10:30–11:30
|
|
Plenary Session 5—ICU—Candida Infections/Breaking News from Hematology and ICU
|
|
|
Chairs: Johan Maertens, FECMM, Belgium / Maricela Valerio, Spain
|
10:30 |
PS5.1 |
Abdominal Candidiasis in ICU Patients |
|
|
Philipp Köhler, FECMM, Germany
|
10:45 |
PS5.2 |
Are the New Management Strategies Useful? |
|
|
Arnaldo Colombo, FECMM, Brazil
|
11:00 |
PS5.3 |
CNS Infections |
|
|
Anna Candoni, Italy
|
11:15 |
PS5.4 |
CMV and Aspergillosis in HSCT Patients |
|
|
Johan Maertens, FECMM, Belgium
|
11:30–12:30
|
|
Poster Session 2
|
11:30
|
|
Video Session
|
11:30 |
V01 |
Subcutaneous Nodule Caused by Phaeoacremonium fuscum in a Non-Immunocompromised Patient |
|
|
Sofie Colman, Belgium
|
11:40 |
V02 |
Trichosporon Diagnosis—The Right Path |
|
|
Thayanidhi Premamalini, India
|
11:50 |
V03 |
Disseminated Rhinosporidiosis with Different Morphological Lesions Involving Various Anatomical Sites |
|
|
Jagdish Chander, India
|
14:15–15:45
|
|
Parallel Symposia 15–19
|
Symposium 15
|
|
Aspergillus in the ICU
|
|
|
Chairs: Katrien Lagrou, FECMM, Belgium & Alessandro Pasqualotto, FECMM, Brazil
|
14:15 |
S15.1 |
Influenza |
|
|
Joost Wauters, Belgium
|
14:35 |
S15.2 |
Invasive Aspergillosis in Patients with Underlying Liver Cirrhosis |
|
|
Juergen Prattes, Austria
|
14:55 |
S15.3 |
Renal Failure |
|
|
Riina Richardson Rautema, FECMM, UK
|
15:15 |
S15.4* |
Fungal Pneumonia in Critically Ill Cirrhotics: Spectrum, Outcomes, Comparison of Diagnostic Methods and Biomarkers |
|
|
Pratibha Kale, India
|
15:25 |
S15.5* |
IPAFLU Survey: Invasive Aspergillosis among Patients with Severe Influenza in Intensive Care Units |
|
|
Joost Wauters, Belgium
|
15:35 |
S15.6* |
Trend of Candidemia with Bloodstream Infection in Intensive Care Units from 2006 to 2017: Results from the Korean National Healthcare-Associated Infections Surveillance System |
|
|
Young Hwa Choi, Korea
|
Symposium 16
|
|
Dermatology
|
|
|
Chairs: Valentina Arsic Arsenijevic, ECMM, Serbia & Sevtap Arıkan Akdagli, FECMM, Turkey
|
14:15 |
S16.1 |
Cutaneous Aspergillosis, Is It So Rare? |
|
|
Sevtap Arıkan Akdagli, FECMM, Turkey
|
14:35 |
S16.2 |
Is Resistance a Problem for Dermatophytosis? |
|
|
Pietro Nenoff, Germany
|
14:55 |
S16.3 |
Phaeohyphomycosis |
|
|
Teresa Martin, Spain
|
15:15 |
S16.4 |
Blastomycosis |
|
|
Ilan Schwarz, Canada
|
15:35 |
S16.5* |
Galleria mellonella as a Novelty Model to Study Host—Pathogen Interaction in Malassezia furfur CBS 1878 |
|
|
Adriana Marcela Celis Ramírez, Colombia
|
Symposium 17
|
|
HIV-Associated Cryptococcal Meningitis
|
|
|
Chairs: John Perfect, USA & Olivier Lortholary, France
|
14:15 |
S17.1 |
Screening in Low-Resource Areas |
|
|
Elvis Temfack, Cameroon
|
14:35 |
S17.2 |
Current Therapeutic Strategies |
|
|
Olivier Lortholary, France
|
14:55 |
S17.3 |
Towards Having Antifungal Drugs in Low-Resource Areas |
|
|
Ida Kolte, UK
|
15:15 |
S17.4 |
Early versus Delayed Antiretroviral Treatment in HIV-Positive People with Cryptococcal Meningitis |
|
|
Tihana Bicanic, FECMM, UK
|
15:35 |
S17.5 |
Current and Future Clinical Trials on HIV-Associated Cryptococcal Meningitis |
|
|
Tom Harrison, UK
|
Symposium 18
|
|
Antifungal Stewardship in the Era of Resistance
|
|
|
Chairs: Paul Verweij, FECMM, The Netherlands & Souha Kanj, FECMM Lebanon
|
14:15 |
S18.1 |
Antifungal Stewardship: A Practical Experience in a Tertiary Care Institution |
|
|
Maricela Valerio, Spain
|
14:35 |
S18.2 |
Stewardship and Azole-Resistant Aspergillosis: A Challenge for Farmer or Physician? |
|
|
Paul Verweij, FECMM, The Netherlands
|
14:55 |
S18.3 |
Rapid Diagnosis of Fungal Infections: Impact on Stewardship |
|
|
Souha Kanj, FECMM, Lebanon
|
15:15 |
S18.4 |
Mycology Laboratory Diagnostic Capabilities in Different Areas of the World |
|
|
Alessandro Pasqualotto, FECMM, Brazil
|
15:35 |
S18.5* |
Optimising Antifungal Stewardship: An Evaluation of Candidaemia Guideline Compliance and Clinical Outcome |
|
|
Laura Cottom, UK
|
Symposium 19
|
|
Pneumocystis
|
|
|
Chairs: Enrique Calderon, Spain & Stephane Bretagne, FECMM, France
|
14:15 |
S19.1 |
Diagnosis |
|
|
Alexandre Alanio, FECMM, France
|
14:40 |
S19.2 |
Pneumocystosis in HIV and Non-HIV Patients |
|
|
Joseph Kovacs, USA
|
15:05 |
S19.4 |
Pneumocystosis in Neonates |
|
|
Enrique Calderon, Spain
|
15:30 |
S19.5* |
Evaluation of a Novel Commercial Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Pneumocystis jirovecii |
|
|
Dirk Schmidt, Germany
|
16:15–17:45
|
|
Parallel Symposia 20–24
|
Symposium 20
|
|
Candida auris
|
|
|
Chairs: Nelesh Govender, FECMM, South Africa & Anuradha Chowdhary, FECMM, India
|
16:15 |
S20.1 |
Schizophrenic Gram-Negative Yeast Conquering the World |
|
|
Jacques Meis, FECMM, The Netherlands
|
16:35 |
S20.2 |
In the US |
|
|
Tom Chiller, USA
|
16:55 |
S20.3 |
Outbreak Control |
|
|
Alba Ruiz, Spain
|
17:15 |
S20.4 |
In Resource-Limited Countries |
|
|
Anuradha Chowdhary, FECMM, India
|
17:35 |
S20.5* |
Understanding Echinocandin Activity towards Candida auris
|
|
|
Milena Kordalewska, USA
|
Symposium 21
|
|
Immunotherapy for Opportunistic Fungal Infections
|
|
|
Chairs: Carol Garcia-Vidal, Spain & Dimitrios Kontoyiannis, FECMM, USA
|
16:15 |
S21.1 |
CAR-T Cells, NK Cells |
|
|
Dimitrios Kontoyiannis, FECMM, USA
|
16:35 |
S21.2 |
WBC Transfusions |
|
|
Livio Pagano, FECMM, Italy
|
16:55 |
S21.3 |
Cytokines |
|
|
George Chamilos, Greece
|
17:15 |
S21.4* |
Novel Chimeric Antigen Receptor T Cells for Invasive Aspergillosis Immunotherapy |
|
|
Michelle Seif, Germany
|
17:25 |
S21.5* |
Comparison of Circulating Lymphocyte Populations CD4+ and CD8+ T Cells, B and NK lymphocytes According to the Favorable or Worsening Evolution of Patients with Pneumocystosis |
|
|
Eléna Charpentier, France
|
17:35 |
S21.6* |
Glucosylceramides from Lomentospora prolificans Induce Cytokines Production and Increase the Microbicidal Activity of Macrophages |
|
|
Mariana Ingrid Dutra Silva Xisto, Brazil
|
Symposium 22
|
|
NGS and Mycobiota
|
|
|
Chairs: Laurence Delhaes, France & Jean-Pierre Gangneux, FECMM, France
|
16:15 |
S22.1 |
Bacterial–Fungal Interactions at the Airway Mucosa and Implications for Chronic Rhinosinusitis |
|
|
Emily Cope, USA
|
16:35 |
S22.2 |
Respiratory Mycobiome—A Clinical Perspective |
|
|
Robert Krause, FECMM, Austria
|
16:55 |
S22.3 |
Characterization of Indoor Dust Microbiota in Homes of Asthma and Non-Asthma Patients |
|
|
Jean-Pierre Gangneux, FECMM, France
|
17:15 |
S22.4 |
Understanding the Role of the Gut Mycobiome in Health and Disease |
|
|
Maria Vehreschild, FECMM, Germany
|
17:35 |
S22.5* |
An ECMM-ESCMID Survey on Goals and Practices for Mycobiota Characterization Using Next-Generation Sequencing in European Laboratories |
|
|
Jean-Pierre Gangneux, FECMM, France
|
Symposium 23
|
|
The Funny Life of C. albicans in the Oral Tract
|
|
|
Chairs: Marie-Elisabeth Bougnoux, France & Anna Maria Tortorano, Italy
|
16:15 |
S23.1 |
Within-Host Genomic Diversity of Candida albicans in Healthy Carriers |
|
|
Marie-Elisabeth Bougnoux, France
|
16:35 |
S23.2 |
Activation of Oral Immune Responses by C. albicans
|
|
|
Julian Naglik, UK
|
16:55 |
S23.3 |
Modulation of the Fungal–Host Interaction by the Intraspecies Diversity of C. albicans
|
|
|
Dominique Sanglard, Switzerland
|
17:15 |
S23.4 |
Intestinal Th17 Drives Airway Inflammation in ABPA |
|
|
Petra Bacher, Germany
|
17:35 |
S23.5* |
Persistence of Clonal Azole-Resistant Isolates of Candida albicans from a Patient with Chronic Mucocutaneous Candidiasis in Colombia |
|
|
Andres Ceballos-Garzon, Colombia
|
Symposium 24
|
|
Fungal Neglected Tropical Diseases
|
|
|
Chairs: Flavio Queiroz-Telles, Brazil & Leila Lopes Bezerra, Brazil
|
16:15 |
S24.1 |
Mycetoma |
|
|
Wendy van de Sande, FECMM, The Netherlands
|
16:35 |
S24.2 |
Chromoblastomycosis |
|
|
Flavio de Queiroz-Telles, FECMM, Brazil
|
16:55 |
S24.3 |
Sporotrichosis |
|
|
Leila Lopes Bezerra, Brazil
|
17:15 |
S24.4 |
Novel Diagnostic and Treatment Strategies for the Southeast Asian Fungus Talaromyces marneffei
|
|
|
Thuy Le, USA
|
17:25 |
|
Discussion |